{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:12:48Z","timestamp":1788372768210,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004489","name":"MITACS","doi-asserted-by":"crossref","award":["Accelerate program"],"award-info":[{"award-number":["Accelerate program"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Provincial and national case definitions for healthcare-associated infections (HAI) differ. A key question is the extent to which these differences impact the estimated case proportions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Analyses focused on two infections:\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (CDI) and methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA). After identifying divergent elements in definitions, a parametric simulation was conducted using a multivariate Bernoulli model to generate elements, incorporating assumed relationships between them and necessary sample sizes. A reference simulation was performed using the original proportions of elements as reported in the literature. This reference served as a baseline for comparison with simulations in which the proportions of discordant elements varied between provincial and national case definitions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine discordant elements were identified for CDI and six for MRSA. Simulations showed comparability between provincial and national HAI proportions. The greatest differences between provincial and national proportions occurred for Newfoundland and Labrador (CDI) and Ontario (MRSA). These differences persisted even in the reference simulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although adopting a standardized case definition would simplify comparisons, provincial case definitions are generally comparable to the national definition. Results should be interpreted with care, especially when estimating case proportions under extreme values for some characteristics, as the joint distributions we used for generating simulated datasets did not necessarily exist nor represent target marginal proportions or associations between elements in some scenarios. To improve comparability, hospitals should calculate both the number of patients with positive CDI or MRSA results and their proportion of all elements used in case definitions to have a better picture of their patient demographics. This information could further help the Canadian Nosocomial Infection Surveillance Program (CNISP) to describe comparability across provinces.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12963-026-00508-y","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:05:32Z","timestamp":1787623532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["National healthcare-associated infections surveillance programs \u2013 comparison between provincial and national case definitions in Canada"],"prefix":"10.1186","volume":"24","author":[{"given":"Etienne","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"MacLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-841X","authenticated-orcid":false,"given":"Janie","family":"Coulombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"4","key":"508_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jiph.2014.04.003","volume":"7","author":"JA Al-Tawfiq","year":"2014","unstructured":"Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339\u201344.","journal-title":"J Infect Public Health"},{"issue":"22","key":"508_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","volume":"173","author":"E Zimlichman","year":"2013","unstructured":"Zimlichman E, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039\u201346.","journal-title":"JAMA Intern Med"},{"key":"508_CR3","unstructured":"Branch, M.P.H., Clostridioides difficile Infection (CDI). 2019."},{"key":"508_CR4","unstructured":"CNISP, Canadian nosocomial infection surveillance program surveillance for clostridioides difficile infection (CDI) CDI Surveillance Protocol. 2023."},{"key":"508_CR5","unstructured":"INSPQ, Surveillance provinciale des diarrh\u00e9es \u00e0 Clostridium difficile au Qu\u00e9bec: protocole de surveillance. 2024."},{"key":"508_CR6","unstructured":"Provincial Infection Control Network of British Columbia (PICNet). Surveillance protocol for Clostridium difficile infections (CDI) in BC acute care facilities. 2022."},{"key":"508_CR7","doi-asserted-by":"crossref","unstructured":"Poirier E, Boulanger V, MacLaurin A, Frenette C, Varsaneux O, Quach C. National healthcare-associated infections surveillance programs\u2014concordance between provincial and CNISP case definitions. Can Commun Dis Rep. 2025.","DOI":"10.1186\/s12963-026-00508-y"},{"key":"508_CR8","unstructured":"Manitoba Health, S.a.A.L., Manitoba Health, Seniors and Active Living ARO Definitions. n.d."},{"key":"508_CR9","unstructured":"Saskatchewan, Clostridium difficile infection (CDI) surveillance protocol: Saskatchewan. 2016."},{"key":"508_CR10","unstructured":"PIC-NL, Provincial surveillance protocol for clostridium difficile infection. 2013."},{"key":"508_CR11","unstructured":"PIC-NL, Provincial surveillance protocol for methicillin-resistant Staphylococcus aureus. 2022."},{"key":"508_CR12","unstructured":"PHO, Best practices for surveillance of health care-associated infections. 2014."},{"key":"508_CR13","unstructured":"NSHW, Protocol for healthcare-associated clostridium difficile infection surveillance for acute care hospitals in Nova Scotia. 2015."},{"key":"508_CR14","unstructured":"NSHW, Protocol for healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection surveillance in acute care hospitals in Nova Scotia. 2015."},{"key":"508_CR15","unstructured":"AHS, Bloodstream infection (BSI) protocol. 2024."},{"key":"508_CR16","unstructured":"AHS, Methicillin-resistant Staphylococcus aureus (MRSA) protocol. 2024."},{"key":"508_CR17","unstructured":"AHS, Clostridium difficile infection (CDI) protocol. 2024."},{"key":"508_CR18","unstructured":"Provincial Infection Control Network of British Columbia (PICNet). Surveillance protocol for methicillin-resistant Staphylococcus aureus (MRSA) in BC acute care facilities. 2022."},{"key":"508_CR19","unstructured":"INSPQ, Surveillance provinciale des bact\u00e9ri\u00e9mies \u00e0 Staphylococcus aureus au Qu\u00e9bec: protocole de surveillance. 2024."},{"key":"508_CR20","unstructured":"Ontario, H., Antibiotic-resistant bloodstream infections. 2017."},{"key":"508_CR21","unstructured":"CIHI, S\u00e9jours hospitaliers au Canada, 2022-2023. 2024."},{"issue":"2","key":"508_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1086\/502522","volume":"26","author":"SE Cosgrove","year":"2005","unstructured":"Cosgrove SE, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166\u201374.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"508_CR23","doi-asserted-by":"publisher","first-page":"ofae127","DOI":"10.1093\/ofid\/ofae127","volume":"11","author":"AY Guh","year":"2024","unstructured":"Guh AY, et al. Characteristics of patients with initial clostridioides difficile infection (CDI) that are associated with increased risk of multiple CDI recurrences. Open Forum Infect Dis. 2024;11(4):ofae127.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"508_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1128\/JCM.05711-11","volume":"50","author":"A Kaltsas","year":"2012","unstructured":"Kaltsas A, et al. Clinical and laboratory characteristics of clostridium difficile infection in patients with discordant diagnostic test results. J Clin Microbiol. 2012;50(4):1303\u20137.","journal-title":"J Clin Microbiol"},{"key":"508_CR25","doi-asserted-by":"crossref","unstructured":"Matok LA, et al. Mother-to-neonate transmission of antibiotic-resistant bacteria: a cross-sectional study. Microorganisms. 2021;9(6).","DOI":"10.3390\/microorganisms9061245"},{"issue":"Suppl 4","key":"508_CR26","doi-asserted-by":"publisher","first-page":"iv55","DOI":"10.1093\/jac\/dkz288","volume":"74","author":"KA Nichol","year":"2019","unstructured":"Nichol KA, et al. Characterization of MRSA in Canada from 2007 to 2016. J Antimicrob Chemother. 2019;74(Suppl 4):iv55\u201363.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"508_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ajic.2019.01.007","volume":"47","author":"E Verheyen","year":"2019","unstructured":"Verheyen E, et al. High 30-day readmission rates associated with clostridiumdifficile infection. Am J Infect Control. 2019;47(8):922\u20137.","journal-title":"Am J Infect Control"},{"key":"508_CR28","doi-asserted-by":"crossref","unstructured":"Viprey VF, et al. A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Euro Surveill. 2022;27(26).","DOI":"10.2807\/1560-7917.ES.2022.27.26.2100704"},{"issue":"5","key":"508_CR29","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1128\/JCM.03147-14","volume":"53","author":"SH Wang","year":"2015","unstructured":"Wang SH, et al. Molecular and clinical characteristics of hospital and community onset methicillin-resistant Staphylococcus aureus strains associated with bloodstream infections. J Clin Microbiol. 2015;53(5):1599\u2013608.","journal-title":"J Clin Microbiol"},{"key":"508_CR30","unstructured":"INSPQ, Diarrh\u00e9es \u00e0 Clostridioides difficiles au Qu\u00e9bec, 2022\u20132023. 2023."},{"key":"508_CR31","unstructured":"INSPQ, Bact\u00e9ri\u00e9mies \u00e0 Staphylococcus aureus r\u00e9sistant \u00e0 la m\u00e9thicilline au Qu\u00e9bec, 2022\u20132023. 2023."},{"key":"508_CR32","unstructured":"Provincial Infection Control Network of British Columbia (PICNet). Quarter four (Q4) of 2023\/24 (November 10, 2023 \u2013 March 31, 2024) Quarterly surveillance report. 2024."},{"key":"508_CR33","unstructured":"NSHW, Public reporting on patient safety. 2024."},{"key":"508_CR34","unstructured":"Ontario, H.Q., Hospital patient safety. 2024."},{"key":"508_CR35","unstructured":"PIC-NL, Healthcare-associated infections annual report 2011-2017. 2018."},{"key":"508_CR36","unstructured":"Saskatchewan, Clostridium difficile infection (CDI) surveillance report: Saskatchewan 2017-18 2018."},{"key":"508_CR37","unstructured":"Winnipeg Regional Health Authority (WRHA). Winnipeg acute care summary of healthcare associated infections of Clostridioides difficile and methicillin resistant Staphylococcus aureus. 2022."},{"key":"508_CR38","unstructured":"PEI H. Prince Edward Island: infection prevention and control surveillance data summary 2016. 2017."},{"key":"508_CR39","unstructured":"INSPQ, Surveillance provinciale des infections nosocomiales \u2013 Diarrh\u00e9es \u00e0 Clostridioides difficile 2021-2022. 2022."},{"issue":"3","key":"508_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1467-9469.2012.00802.x","volume":"39","author":"BF Qaqish","year":"2012","unstructured":"Qaqish BF, Zink RC, Preisser JS. Orthogonalized residuals for estimation of marginally specified association parameters in multivariate binary data. Scand Stat Theory Appl. 2012;39(3):515\u201327.","journal-title":"Scand Stat Theory Appl"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12963-026-00508-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-026-00508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:57:30Z","timestamp":1788335850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12963-026-00508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/s12963-026-00508-y","relation":{},"ISSN":["1478-7954"],"issn-type":[{"value":"1478-7954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A MacLaurin is an employee of Healthcare Excellence Canada. The other authors have no conflict of interest to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}